According to current concepts, acidification of the urine in the distal tubule and final removal of bicarbonate from the glomerular filtrate occur by a process of ion exchange in which hydrogen ions within tubular cells are exchanged for sodium in the filtrate (1) . It is thought that carbonic anhydrase catalyzes an essential reaction which either directly supplies hydrogen ions to the exchange site or removes the base generated by the secretion of hydrogen ions. In support of this hypothesis is the fact that unsubstituted sulfonamides which inhibit carbonic anhydrase prevent acidification of the urine and produce a diuresis of sodium and bicarbonate. Using sulfanilamide, Pitts and Alexander found that approximately 20 per cent of the filtered bicarbonate could be diverted into the urine (2) , and suggested that the reabsorption of bicarbonate in the distal tubule was dependent on carbonic anhydrase activity.
Subsequently, however, it was pointed out by Berliner (3) and by Schwartz, Danzig and Relman (4) that acetazolamide, a more potent sulfonamide inhibitor of carbonic anhydrase, is capable of producing much greater effects on bicarbonate reabsorption. A dose of 20 to 30 mg per kg of acetazolamide resulted in the loss of up to 50 per cent of the filtered bicarbonate, thus suggesting that a * Supported in part by Public Health Service Grants A-330 and H-759 from the National Heart Institute, Bethesda, Md., and by a grant from the American Heart Association. Presented in part before the 76th annual meeting of the American Physiological Society, April, 1956. t This sodium-hydrogen exchange catalyzed by carbonic anhydrase might be responsible for the reabsorption of bicarbonate in the proximal as well as distal tubules (3, 4) . With intravenous doses of 500 mg per kg, even greater effects have been observed, with more than 75 per cent of the filtered bicarbonate appearing in the urine for a brief period after injection (5) . Simultaneously, there was an enormous but transient diuresis, in which more than half of the filtered sodium and water was excreted.
These experiments were at first interpreted (4) as showing that the mechanism by which most, if not all, sodium reabsorption is accomplished involves the carbonic anhydrase-dependent hydrogen exchange described above. However, a more recent examination of this problem, using an N2-methyl analog (CL 8490) of acetazolamide which has little or no enzyme-inhibiting activity, indicates that this drug also is a potent diuretic when given in comparably large doses (5 increase in chloride excretion and, although potassiuml excretion increased, most of the increment in bicarbonate was associated with a nearly equivalent rise in sodium excretion. Significant levels of carbonic anhydrase inhibiting activity were demonstrable in both plasma and urine. Urine flow increased slightly despite a drop in glomerular filtration rate. Injection of 10.6 mg per kg of CL 8490 on five other occasions was similarly without effect on water and electrolyte excretion. Acetazolamide in this dose never failed to produce a significant reduction in bicarbonate reabsorption, but in no case increased chloride excretion.
II. The effects of 500 nig per1 kg of acetazolamide. In 15 experiments acetazolamide was administered intravenously at a dose of 500 mg per kg. On five occasions the drug was injected 2 to 3 hours after a comparable dose of analog, and in the remaining 10 experiments acetazolamide alone was injected. In Table II are summarized the results of two such experiments. In the first experiment (A), the dog had not received any other agent prior to injection of acetazolamide; in the other (B), a large dose of CL 8490 had been given approximately 90 minutes before, but its effect lhad almost entirely disappeared prior to injection of acetazolamide.
In both instances, injection of 500 mg per kg of acetazolamide resulted in a significant rise in blood pH and plasma bicarbonate concentration. There was also a very large diuresis of water and electrolytes. At The maximal excretion of sodium and water was 20 to 57 per cent, and of chloride 13 to 45 per cent of the filtered load. As in the experiments in Table II , the glomerular filtration rate usually dropped slightly after the injection, but in a few cases there was no change. Qualitative tests of the urine for sugar in three experiments were negative. Phosphorus excretion, measured in sev- Acetazolamide has a pKa', of 7.4 and a pKa'2 of 9.1; the drug was injected at a pH of between 8.5 and 9.0 and was titrated by the blood to a pH of approximately 7.4 to 7.6. Therefore, it can be estimated that each buffer group would be titrated by approximately 0.5 equivalent per mole, or a total of 1 mEq per mmole of drug administered. Since the total dose of drug was approximately 2 (8) and with urea (9) . It is apparent that sodium excretion at any given rate of water excretion was considerably less with osmotic diuresis than with the drugs studied here. To the authors' knowledge, the maximal rates of sodium excretion observed in the given, there was little or no effect on chloride, and almost all of the increment in anion was due to bicarbonate (Table I) . By contrast, in the present experiments with 500 mg per kg, although there was a further enhancement of bicarbonate excretion, a large part of the increased excretion of anion was due to chloride.
The explanation for this phenomenon was at first thought to reside solely in the carbonic anhydrase inhibiting activity of the large dose (4). It would now appear that an additional mechanism must be invoked because equimolar large doses of an inactive analog (CL 8490) also produce a substantial diuresis of electrolyte and water. This diuresis is not usually as large as that resulting from acetazolamide, but closely resembles the latter in its duration and in its effect on urine composition.
It seems clear from the data at hand that neither the osmotic effect nor the acute systemic alkalinizing action of the large dose of the sodium salts of acetazolamide or CL 8490 can explain the results. is possible that the diuretic action shared by acetazolamide and C(7 8490 resides in some other property of the thiadiazole-sulfonamide configuration which also belongs to the benzothiadiazole-sulfonamides of the chlorothiazide family. The latter are potent saluretics which in relatively low dosage produce changes in electrolyte excretion qualitatively similar to those reported here (12, 13 
